FY25 consensus $258.58M. Backs FY25 net product sales guidance in the range of $240M-$250M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUPH:
- Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results
- Aurinia Pharmaceuticals to Announce Q1 2025 Results
- Glass Lewis Supports Aurinia’s Proposals for 2025 AGM
- Aurinia Pharmaceuticals’ proposals receive recommendation from Glass Lewis
- ISS Endorses Aurinia’s Proposals for 2025 Annual Meeting
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue